Executive Interview – Crescendo

Executive Interview – Crescendo

Crescendo Biologics is a Cambridge-based, cancer-focused drug discovery and development company with a proprietary transgenic VH mouse platform and rapid formatting capabilities that are used to create its therapeutic product candidates, Humabodies. Humabodies are built from fully human single-domain antibody VH fragments (heavy chain variable domain) generated by a proprietary triple knockout transgenic mouse (Crescendo mouse) and can be bispecific or multi-specific. Its initial focus is on the development of Humabody drug conjugates (HDCs) and multi-specific checkpoint modulators.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free